<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>STTR Phase I:  DNA Assembly for Directed Expression of Industrial Enzymes Using a Novel Hyperthermophilic Genome</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>07/01/2006</AwardEffectiveDate>
<AwardExpirationDate>10/31/2007</AwardExpirationDate>
<AwardTotalIntnAmount>0.00</AwardTotalIntnAmount>
<AwardAmount>100000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>F.C. Thomas Allnutt</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>This Small Technology Transfer Research (STTR) Phase I project aims to exploit a newly sequenced genome of a hyperthermophilic microorganism for the production of thermal stable enzymes that are useful for molecular engineering and industrial application. The targeted DNA coding regions can be prepared for recombinant protein expression without extended manipulations in restriction digest and ligation reactions. Small-scale production of targeted gene products can be quickly evaluated for solubility and stability to determine potential scale-up production. The procedure is most attractive for future studies to implement point mutations, create chimeric enzymes and perform domain shuffling for optimizing enzyme functionality.&lt;br/&gt;&lt;br/&gt;The impact of the proposal is of significant commercial value as well as having social impact in production new biocatalytic protein that may be more robust and thermal stable for industrial processes, including detergents, textile, food processing, medical applications and energy. Moreover, novel enzymes that are more active and effective for drug intermediates would be immensely useful for biotransformation in the pharmaceutical industry and consequently affect world health in general.&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>06/07/2006</MinAmdLetterDate>
<MaxAmdLetterDate>08/29/2007</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0611274</AwardID>
<Investigator>
<FirstName>Damien</FirstName>
<LastName>Marsic</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Damien Marsic</PI_FULL_NAME>
<EmailAddress>damien.marsic@gmail.com</EmailAddress>
<PI_PHON>3523278212</PI_PHON>
<NSF_ID>000349971</NSF_ID>
<StartDate>06/07/2006</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Extremozyme Inc.</Name>
<CityName>Huntsville</CityName>
<ZipCode>358990001</ZipCode>
<PhoneNumber>2568242413</PhoneNumber>
<StreetAddress>301 Sparkman Dr.</StreetAddress>
<StreetAddress2><![CDATA[Material Science Building, UAH]]></StreetAddress2>
<CountryName>United States</CountryName>
<StateName>Alabama</StateName>
<StateCode>AL</StateCode>
<CONGRESSDISTRICT/>
<CONGRESS_DISTRICT_ORG/>
<ORG_DUNS_NUM>614372535</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>IXPRESSGENES, INC.</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[University of Alabama in Huntsville]]></Name>
<CityName>Huntsville</CityName>
<StateCode>AL</StateCode>
<ZipCode>358051911</ZipCode>
<StreetAddress><![CDATA[301 Sparkman Drive]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Alabama</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>05</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF/>
</Performance_Institution>
<FoaInformation>
<Code>0110000</Code>
<Name>Technology Transfer</Name>
</FoaInformation>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>1505</Code>
<Text>STTR Phase I</Text>
</ProgramElement>
<ProgramElement>
<Code>9150</Code>
<Text>EPSCoR Co-Funding</Text>
</ProgramElement>
<ProgramReference>
<Code>9150</Code>
<Text>EXP PROG TO STIM COMP RES</Text>
</ProgramReference>
<ProgramReference>
<Code>9183</Code>
<Text>GENERAL FOUNDATIONS OF BIOTECHNOLOGY</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
<Appropriation>
<Code>0106</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0406</Code>
<Name>NSF,Education &amp; Human Resource</Name>
<APP_SYMB_ID>490106</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2006~100000</FUND_OBLG>
</Award>
</rootTag>
